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Fru 2,6-Pz was present in isolated foetal bepatocytes at a concentration of 1.6 nmol per g cells. When foetal 
hepatocytes were exposed to glucagon no changes were observed either in the concentration of Fru 2,6-P* 
and lactate release or in the activities of 6-phosphofructo-2-kinase and pyruvate kinase. Incubation of puri- 
fied 6-phosphofructo-2-kinase withthe catalytic subunit of protein kinase did not change the enzyme activi- 
ty. The inhibition by sn-glycerol 3-phosphate was much lower for the foetal than for adult enzyme. These 
results suggest hat an isoenzyme of 6-phosphofructo-2-kinase in foetal hepatocytes different from that of 
adult hepatocytes may be present. 
6-Phosphofructo-2-kinase; Fructose 2,6_bisphosphate; Glucagon; (Fetal hepatocyte) 
1. INTRODUCTION 
One of the characteristics of the perinatal period 
is the presence of hepatic isoenzymes for car- 
bohydrate metabolism different from those 
prevailing in adult tissues. As a result, foetal liver 
actively carries out glycolysis and fails to achieve 
gluconeogenesis [ 11. 
In adult liver, fructose 2,6-bisphosphate plays 
an important role in the control of the metabolic 
fluxes through 6-phosphofructo-1-kinase and 
fructose-l ,6_bisphosphatase. Both enzymes are 
present in the 22-day-old foetus showing activities 
similar to those found in adult hepatocytes [2]. 
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Changes in Fru 2,6-PZ have been described in 
liver homogenates during the perinatal period [3]. 
However, foetal liver contains large amounts of 
haematopoietic cells, and recently it has been 
reported [4] that erythrocytes may interfere in the 
measurement of Fru 2,6-Pz. In order to eliminate 
these interferences we have used isolated foetal 
hepatocytes in this study. 
The influence of hormonal changes on the con- 
trol of Fru 2,6-PZ concentration and on 
6-phosphofructo-2-kinase is little understood. The 
present work suggests that foetal hepatocytes con- 
tain an isoenzyme of PFK-2 different from that of 
adult hepatocytes. 
2. MATERIALS AND METHODS 
2.1. Animals 
Albino Wistar pregnant rats (300-350 g) fed on 
a standard laboratory diet were killed for the ex- 
periments between 09:OO and 10:00 h. Gestational 
age was confirmed by standard criteria [5]. 
Newborn rats were delivered by caesarean section 
in the morning of day 22 of gestation and were 
used immediately. 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/87/$3.50 0 1987 Federation of European Biochemical Societies 37 
Volume 225, number 1,2 FEBS LETTERS December 1987 
2.2. Isolation of hepatocytes 
Hepatocytes from foetal rat liver were prepared 
by a non-perfusion collagenase dispersion method 
that involved incubation with Ca’+-free Krebs 
bicarbonate buffer [6], containing 0.5 mM EGTA 
for 30 min at 37°C under continuous gassing 
(OZ/COZ, 19: 1). The cell suspension was cen- 
trifuged (50 x g for 2 min), incubated for 60 min 
in the presence of 5 mM Ca2+ and 0.5 mg/ml of 
collagenase, centrifuged (50 x g for 4 min) and 
filtered through nylon of different meshes 
(500-50 pm). Separation of parenchymal from 
haematopoietic cells was carried out by washing 
the suspension at very low speed. Haematopoietic 
cell contamination was shown by microscopic 
observation to be less than 5%. Cells obtained (ap- 
prox. 1.5 x lo7 cells/g liver) resulted in about 15% 
recovery. Cell viability (trypan blue exclusion and 
lactate dehydrogenase activity) was always higher 
than 90%. Hepatocytes from adult rats were 
prepared as in [7]. Hepatocytes (5-7 x lo6 
cells/flask) were incubated for 30 min at 37°C in 
Krebs bicarbonate in a final volume of 3 ml in the 
presence or absence of glucagon. 
2.3. PFK-2 purification 
Foetal and adult hepatocytes (2-3 g) were 
homogenized in a buffer containing 100 mM 
KC1/5 mM MgCW2 mM DTT/SO mM Hepes (pH 
7.4). After centrifugation (100000 x g for 1 h) the 
supernatant was fractionated with polyethylene 
glycol. The 6- 15% pellet was resuspended in 5 ml 
homogenising medium supplemented with 20% 
(v/v) glycerol and passed through a column (2 x 
0.5 cm) of Blue Sepharose. PFK-2 was eluted with 
a gradient (50-1000 mM) of KC1 as described by 
Van Schaftingen et al. [8]. Both enzymes eluted as 
approx. 500-600 mM KCl. 
2.4. Measurements of enzymes and metabolites 
Fructose 2,6-bisphosphate was measured as 
described by Van Schaftingen et al. [9] and lactate 
as in [lo]. CAMP was assayed using binding pro- 
tein with the Amersham (England) kit. For the 
measurement of enzymes, samples were im- 
mediately frozen in a solid COJacetone bath. 
Cells were homogenized at 4°C with an Ultra- 
turrax in a medium containing 20 mM potassium 
phosphate/l mM EDTAIl mM KC111 mM 
DTT/SO mM NaF (pH 7). After centrifugation 
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(20000 x g for 20 min at 4°C) the supernatant was 
assayed for pyruvate kinase at pH 7.4 in the 
presence of 1 mM ADP and 0.15 or 5 mM 
phosphoenolpyruvate as described by Feliu et al. 
[ 111. Fructose- 1,6_bisphosphatase was assayed 
with 0.1 mM Fru 1,6-P2 as described by Van 
Schaftingen and Hers [ 121. 6-Phosphofructo-2- 
kinase activity was measured after precipitation 
with 15% polyethylene glycol [13] and resuspen- 
sion in the extraction medium without NaF. The 
‘active’ form of PFK-2 was measured at pH 6.6 in 
the presence of 1 mM fructose 6-phosphate. The 
total activity was measured at pH 8.5 with 5 mM 
fructose 6-phosphate [ 141. The sensitivity of 
PFK-2 activity to sn-glycerol 3-phosphate inhibi- 
tion was determined in a Blue Sepharose-purified 
PFK-2 fraction at pH 7.1 and in the presence of 
0.1 mM Fru 6-P and 0.5 mM MgATP [ 131. PFK-2 
(0.1 mU Blue Sepharose fraction) was incubated in 
0.1 ml at 30°C for 10 min with 0.1 mU catalytic 
subunit of protein kinase in the presence of 
100 mM KC1/5 mM MgC12/1 mM DTT/20 mM 
Hepes (pH 7.0) and 1 mM MgATP [13]. Samples 
(20 ~1) were used to assay PFK-2 activity at pH 6.6 
and 8.5 as previously indicated. 
Fructose-2,6_bisphosphatase was measured in 
this fraction by the production of 32Pi from 10 PM 
Fru 2,6-[2-32P]P2. The assay was performed ac- 
cording to Rider et al. [13]. Fru 2,6-[2-32P]P2 was 
prepared by the method of Van Schaftingen et al. 
[8]. The reaction was linear with time and protein 
concentration. 
The total activity of CAMP-dependent protein 
kinase (PKA) was assayed in supernatants from 
control hepatocytes after filtration through 
Sephadex G-25 by using histone H2 as substrate 
and in the presence or absence of 10pM CAMP, 
according to Corbin and Reimann [ 151. The reac- 
tion was performed under the linear range with 
time and protein concentration. One unit of PKA 
activity was defined as the incorporation of 1 pmol 
32Pi into histone H2 per min. Protein concentra- 
tion was determined by the method of Bradford 
[16] using bovine serum albumin as standard. 
3. RESULTS 
To determine the relative content of Fru 2,6-P2 
in foetal liver vs isolated foetal hepatocytes, livers 
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were immediately homogenized with 50 mM 
NaOH (1: 20, w/v). The content of Fru 2,6-P* was 
1.5 + 0.2 (n = 11) nmol per g liver and 1.6 + 0.2 
(n = 9) nmol per g foetal hepatocytes. 
Foetal hepatocytes contain receptors for 
glucagon and adenylate cyclase activity [ 17,181. To 
investigate whether glucagon-receptor occupancy 
affected the activity of PFK-2 and the concentra- 
tion of Fru 2,6-PZ as occurred in the adult, isolated 
foetal hepatocytes were exposed to lo-’ M 
glucagon for 5 or 30 min and assayed for their con- 
tent of Fru 2,6-Pz, lactate release and PFK-2 and 
PK activities. As shown in table 1 glucagon was in- 
effective at changing any of these parameters; 
however, it was effective when adult hepatocytes 
were used. 
To determine whether glucagon is able to in- 
crease the intracellular concentration of CAMP, 
foetal hepatocytes were incubated with different 
concentrations of the hormone (10-‘“-10-6 M) 
and samples were collected to measure CAMP and 
PFK-2 activity at 5 and 30 min. Fig.1 shows that 
CAMP increased because of the effect of glucagon 
either after 5 or 30 min of incubation. However, 
PFK-2 activity expressed as the activity ratio at pH 
8.5/pH 6.6 did not change at glucagon concentra- 
tions even as high as 1 PM. The maximal increase 
in CAMP (Cfold) was obtained at hormone con- 
centrations in the physiological range (lo-’ M). 
Moreover, the activity of the CAMP-dependent 
protein kinase, assayed with histone H2 as 
GLUCAGON, /Ml 
Fig.1. Effect of glucagon on CAMP concentration and 
PFK-2 activity in foetal hepatocytes. Foetal hepatocytes 
(2-3 x lo6 cells/ml) were incubated with different 
concentrations of glucagon and aliquots (1.5 ml) were 
collected at 5 and 30 min. CAMP concentration and 
PFK-2 activity were assayed as described in section 2. 
Total PFK-2 activity (pH 8.5) was 53 f 11 pmol Fru 
2,6-Pz/min per mg protein for control hepatocytes. 
Results for CAMP are means of duplicates of two 
different experiments. (0, A) CAMP at 5 and 30 min, 
respectively; (0) PFK-2 activity at 30 min. 
substrate, was similar in control adult and foetal 
hepatocytes resulting in 170 f 35 and 215 f 
40 U/mg protein, respectively. These results sug- 
Table 1 
Fru 2,6-PZ content, lactate release, PFK-2 and PK activities in foetal and adult rat hepatocytes exposed to glucagon 
Hepatocytes Addition Fru 2,6-PZ 
(nmol/g cells) 
(5 min) (30 min) 
Foetal none 1.4 * 0.3 1.6 k 0.2 
lo-’ M glucagon 1.4 -+ 0.2 1.3 f 0.2 
Adult none 9.0 * 0.4 8.5 + 0.6 
lo-’ M glucagon 1.7 * 0.3” 1.1 2 0.1” 
a Significance of the differences p < 0.001 
Numbers in parentheses indicate times of incubation. Isolated hepatocytes (5-7 x lo6 cells) were exposed to lo-’ M 
glucagon for 30 min and analysed for their content of Fru 2,6-P2, lactate release and PFK-2 and PK activities. PFK-2 
was measured at pH 6.6 and 8.5 and is expressed as the activity ratio pH 8.516.6. The total activities (pH 8.5) were 
53 + 11 and 155 * 30 pmol Fru 2,6-Pz/min per mg protein for control foetal and adult hepatocytes and 52 f 10 and 
147 + 13, respectively, when glucagon was present. Results are means IC_ SE of at least six different experiments 
Lactate PFK-2 
@mol/g cells) (pH 8.516.6) (V,.$v”, mM) 
(30 min) (30 min) (30 min) 
11.5 f 1.6 1.7 + 0.3 0.66 f 0.07 
10.5 + 1.3 1.7 + 0.3 0.57 f 0.11 
2.6 + 0.4 1.6 + 0.1 0.45 k 0.08 
1.1 f 0.2” 4.2 + 0.6a 0.15 * 0.02a 
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Fig.2. Effect of glucagon on the affinity of PFK-2 for FrudP in foetal and adult hepatocytes. The enzyme was partially 
purified by PEG fractionation and assayed at pH 7.1. Results are expressed as a percentage of the maximal activitiy. 
(A) Foetal hepatocytes, (B) adult hepatocytes. (0) No additions, (0) lo-’ M glucagon. 
gest that foetal liver (22 days), despite exhibiting a 
glucagon-dependent rise in CAMP concentration 
and an activity of CAMP-dependent protein kinase 
similar to that found in adult hepatocytes, lacks 
the hormonal response induced by glucagon on 
PK, PFK-2 and Fru 2,6-Pz that is present in adult 
tissue. 
To characterize better the nature of PFK-2, the 
enzyme was partially purified (15% polyethylene 
glycol pellet) from foetal and adult hepatocytes in- 
cubated in either the absence or presence of 
lo-’ M glucagon. As shown in fig.2, the enzyme 
activity assayed at pH 7.1 had no response to 
glucagon in the foetus, whereas the adult tissue ex- 
hibited the reported change [ 191 in affinity for Fru 
6-P (5-fold) as well as a decrease in maximal activi- 
ty (from 173 to 82 pmol/min per mg protein). 
The incubation of Blue Sepharose-purified 
PFK-2 with the catalytic subunit of CAMP- 
dependent protein kinase could not modify the ac- 
tivity of the foetal enzyme (table 2). The adult en- 
zyme was inhibited when assayed at pH 6.6 
Table 2 
Effect of treatment of PFK-2 with the catalytic subunit of protein kinase 
Hepatocytes Addition PFK-2 activity 
(mU/mg of protein) 
pH 6.6 pH 8.5 
Foetal none 16 + 2 22 * 5 
catalytic subunit + ATP (1 mM) 18 + 3 25 * 3 
Adult none 28 + 3 38 + 5 
catalytic subunit + ATP (1 mM) 10 * 2a 35 + 4 
Blue Sepharose-purified PFK-2 from foetal and adult hepatocytes was incubated with 
0.1 mU catalytic subunit of protein kinase at 30°C for 10 min. Samples were used to 
assay PFK-2 activity at pH 6.6 and 8.5 as indicated in section 2.4 
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Fig.3. Effect of sn-glycerol 3-phosphate on PFK-2 
activity in foetal and adult hepatocytes. Blue Sepharose- 
purified PFK-2 activity was assayed with 0.1 mM Fru 6P 
and 0.5 mM MgATP at pH 7.1. The specific activities of 
adult (0) and foetal (A) PFK-2, corresponding to 100% 
values, were 22 and 38 mU/mg protein. 
whereas no change was observed at pH 8.5 as 
described in [ 121. 
It has been reported that hepatic PFK-2 is very 
sensitive to inhibition by sn-glycerol 3-phosphate 
whereas the heart enzyme is less sensitive [13]. 
PFK-2 from foetal hepatocytes was inhibited by 
sn-glycerol3-phosphate markedly less than was the 
adult enzyme, Ki 2.5 and 0.1 mM respectively 
(fig.3). 
Fructose-2,6_bisphosphatase was measured after 
Blue Sepharose purification. Fractions from foetal 
and adult hepatocytes containing similar PFK-2 
activity (20 mU/mg protein) were assayed for 
fructose-2,6_bisphosphatase activity. Adult hepa- 
tocytes contained 4.1 mU/mg protein, whereas the 
activity of the foetal fraction was lower than 
0.1 mU/mg protein. 
In the 22-day-old foetuses we found a 
fructose-l ,6-bisphosphatase activity of 3.6 U/g 
and 7.7 U/g in adult hepatocytes. This activity was 
inhibited by micromolar concentrations of Fru 
2,6-P2 and AMP. These results suggest that 
changes in the concentration of Fru 2,6-P2 may 
play an important role in the control of the Fru 
6-P/Fru 1,6-P2 futile cycle allowing glycolysis to 
proceed for biosynthetic and energetic purposes. 
4. DISCUSSION 
In the adult liver glucagon plays an important 
role in the regulation of glycogenolysis and 
gluconeogenesis by activating adenylate cyclase 
and increasing CAMP concentration [20]. The 
foetal hepatic adenylate cyclase system is very 
responsive to glucagon [ 181 and it has been sug- 
gested that the development of sensitivity to 
glucagon may be important in the establishment of 
neonatal glucose homeostasis [21]. All of these 
findings are in agreement with our results showing 
that foetal hepatocytes respond to glucagon in- 
creasing CAMP concentration and that the activity 
of the CAMP-dependent protein kinase is similar in 
adult and 22-day-old foetal hepatocytes. 
Here, we report that Fru 2,6-P2 is present in 
isolated foetal hepatocytes at a concentration 
(l-2 nmol/g cells) similar to that found in foetal 
liver. This relatively low concentration of Fru 
2,6-P2 in foetus as compared to that prevailing in 
adult hepatocytes incubated under similar condi- 
tions is enough to activate PFK-1 allowing 
glycolysis to proceed. According to our results, the 
lactate released by foetal hepatocytes was much 
higher than in the adult. This high glycolytic 
capacity of foetal liver has been previously 
reported [2]. 
Because foetal hepatocytes contain receptors for 
glucagon, we investigated the possible existence of 
hormonal control of the concentrations of Fru 
2,6-P2 and of the activity of PFK-2. Our data 
clearly show that foetal PFK-2 was unresponsive to 
glucagon (assayed up to low6 M). 
The analysis of PFK-2 activity showed dif- 
ferences between the adult and foetal enzymes. In- 
cubation of Blue Sepharose-purified PFK-2 with 
the catalytic subunit of the protein kinase failed to 
modify the enzyme activity in foetal hepatocytes. 
Moreover, the sensitivity to sn-glycerol 3-phos- 
phate inhibition was markedly lower for the foetal 
enzyme (more than lo-fold). The activity ratio be- 
tween PFK-2/fructose-2,6-bisphosphatase under 
our conditions was 5 and 200 for adult and foetal 
preparations, respectively. Taken together, these 
results suggest he presence of a PFK-2 enzyme in 
foetal hepatocytes different from that present in 
adult liver. 
Further work is in progress to characterize the 
isoenzymatic form of PFK-2 present in foetal liver. 
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